PCN106 Development of a Guidance for Including Patient-Reported Outcomes (PROs) in Late-Phase Adult Clinical Trials of Oncology Drugs for Comparative Effectiveness Research (CER)
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1223
https://www.valueinhealthjournal.com/article/S1098-3015(12)01288-0/fulltext
Title :
PCN106 Development of a Guidance for Including Patient-Reported Outcomes (PROs) in Late-Phase Adult Clinical Trials of Oncology Drugs for Comparative Effectiveness Research (CER)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01288-0&doi=10.1016/j.jval.2012.03.1223
First page :
A226
Section Title :
Cancer
Open access? :
No
Section Order :
744